scispace - formally typeset
A

Avraham Schweiger

Researcher at University of California, Los Angeles

Publications -  35
Citations -  2743

Avraham Schweiger is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Cognition & Attention deficit hyperactivity disorder. The author has an hindex of 22, co-authored 35 publications receiving 2441 citations.

Papers
More filters
Journal ArticleDOI

Executive Control Deficits as a Prodrome to Falls in Healthy Older Adults: A Prospective Study Linking Thinking, Walking, and Falling

TL;DR: Among healthy older adults, individuals with poorer EF are more prone to falls, and optimal screening, early detection, and treatment of falls should, apparently, also target this cognitive domain.
Journal ArticleDOI

Dual-Task Decrements in Gait: Contributing Factors Among Healthy Older Adults

TL;DR: In this article, the factors that contribute to the dual tasking (DT) changes in performance that occur when older adults walk while simultaneously performing other tasks are not well known, and the authors hypothesized that cognitive and motor reserve (e.g., executive function [EF], postural control, and walking abilities) and affect (e) influence the DT decrements (DTDs) in gait.
Journal ArticleDOI

Executive Function and Falls in Older Adults: New Findings from a Five-Year Prospective Study Link Fall Risk to Cognition

TL;DR: Among community-living older adults, the risk of future falls was predicted by performance on EF and attention tests conducted 5 years earlier, indicating that screening EF will likely enhance fall risk assessment, and that treatment of EF may reduce fall risk.
Journal ArticleDOI

Validity of a novel computerized cognitive battery for mild cognitive impairment.

TL;DR: Mindstreams tests are effective in detecting MCI, providing a comprehensive profile of cognitive function, and the enhanced precision and ease of use of these computerized tests make the NeuroTrax system a valuable clinical tool in the identification of elderly at high risk for dementia.
Journal ArticleDOI

Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial.

TL;DR: The enhanced short-term success rates with nicotine gum in the clinic study are attributed to an effective interaction between use of the active preparation and clinic support, and long-term cessation may require extended maintenance procedures and/or an identification of optimal gum use.